These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25540764)

  • 21. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
    Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
    Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of intravitreal bevacizumab and triamcinolone acetonide theraphies for diffuse diabetic macular edema.
    Aksoy S; Yilmaz G; Akkoyun I; Yazici AC
    Int J Ophthalmol; 2015; 8(3):550-5. PubMed ID: 26086006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bevacizumab for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.
    Lu Y; Su L; Xu X
    J Ocul Pharmacol Ther; 2013 Oct; 29(8):702-8. PubMed ID: 23746130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effectiveness of intravitreal bevacizumab with or without triamcinolone acetonide for treatment of diabetic macular edema.
    Jin E; Luo L; Bai Y; Zhao M
    Ann Pharmacother; 2015 Apr; 49(4):387-97. PubMed ID: 25622852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of subthreshold diode micropulse laser photocoagulation on treating patients with refractory diabetic macular edema.
    Akhlaghi M; Dehghani A; Pourmohammadi R; Asadpour L; Pourazizi M
    J Curr Ophthalmol; 2019 Jun; 31(2):157-160. PubMed ID: 31317093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial macular thickness and response to treatment in diabetic macular edema.
    Soheilian M; Ramezani A; Yaseri M; Mirdehghan SA; Obudi A; Bijanzadeh B
    Retina; 2011 Sep; 31(8):1564-73. PubMed ID: 21451442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema.
    Synek S; Vojniković B
    Coll Antropol; 2010 Apr; 34 Suppl 2():99-103. PubMed ID: 21305729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sub-threshold micro-pulse diode laser treatment in diabetic macular edema: A Meta-analysis of randomized controlled trials.
    Qiao G; Guo HK; Dai Y; Wang XL; Meng QL; Li H; Chen XH; Chen ZL
    Int J Ophthalmol; 2016; 9(7):1020-7. PubMed ID: 27500112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two Doses of Intravitreal Ziv-Aflibercept versus Bevacizumab in Treatment of Diabetic Macular Edema: A Three-Armed, Double-Blind Randomized Trial.
    Baghi A; Jabbarpoor Bonyadi MH; Ramezani A; Azarmina M; Moradian S; Dehghan MH; Nourinia R; Peyman GA; Yaseri M; Soheilian M
    Ophthalmol Retina; 2017; 1(2):103-110. PubMed ID: 31047266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis of the effect of intravitreal bevacizumab versus intravitreal triamcinolone acetonide in central retinal vein occlusion.
    Jin ZY; Zhu D; Tao Y; Wong IY; Jonas JB
    J Ocul Pharmacol Ther; 2013 Nov; 29(9):826-31. PubMed ID: 23971622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of intravitreal ranibizumab for diabetic macular edema in vitrectomized versus non-vitrectomized eyes: a Meta-analysis.
    Wang YH; Xu Q; Luan J
    Int J Ophthalmol; 2024; 17(4):729-735. PubMed ID: 38638245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.
    Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G
    Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravitreal Bevacizumab with or without triamcinolone for refractory diabetic macular oedema.
    Synek S; Veselý P
    Coll Antropol; 2011 Sep; 35(3):841-5. PubMed ID: 22053565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of intravitreal bevacizumab as monotherapy and in combination with macular grid laser photocoagulation in diffuse diabetic macular edema.
    Das GK; Sahu PK; Biakthangi LVL; Jain D
    Oman J Ophthalmol; 2018; 11(3):248-253. PubMed ID: 30505116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of conbercept and ranibizumab for the treatment efficacy of diabetic macular edema: a Meta-analysis and systematic review.
    Liu WS; Li YJ
    Int J Ophthalmol; 2019; 12(9):1479-1486. PubMed ID: 31544046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal fasudil combined with bevacizumab for treatment of refractory diabetic macular edema; a pilot study.
    Nourinia R; Ahmadieh H; Shahheidari MH; Zandi S; Nakao S; Hafezi-Moghadam A
    J Ophthalmic Vis Res; 2013 Oct; 8(4):337-40. PubMed ID: 24653821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
    Liu Q; Hu Y; Yu H; Yuan L; Hu J; Atik A; Guan M; Li D; Li X; Tang S
    Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of intravitreal bevacizumab and macular photocoagulation for treatment of diabetic macular edema in a tertiary care eye hospital, Karachi.
    Jafri AS; Aziz-Ur-Rehman ; Mirani AH; Memon S
    Pak J Med Sci; 2017; 33(5):1215-1219. PubMed ID: 29142567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial.
    Lim JW; Lee HK; Shin MC
    Ophthalmologica; 2012; 227(2):100-6. PubMed ID: 21997197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination therapy with intravitreal bevacizumab and macular grid and scatter laser photocoagulation in patients with macular edema secondary to branch retinal vein occlusion.
    Yang CS; Liu JH; Chung YC; Chou YB; Hung KH
    J Ocul Pharmacol Ther; 2015 Apr; 31(3):179-85. PubMed ID: 25715024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.